Department of General Surgery, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Surg Today. 2021 Jul;51(7):1126-1134. doi: 10.1007/s00595-020-02203-3. Epub 2021 Jan 3.
The insufficient clearance of regional lymph nodes and unsatisfactory R0 resection rate may result in the metastasis of left-sided pancreatic ductal adenocarcinoma (PDAC) after conventional distal pancreatosplenectomy (CDPS). Radical antegrade modular pancreatosplenectomy (RAMPS) was designed to achieve R0 resection more successfully with better lymph-node clearance; however, there is still insufficient evidence of its short- and long-term results to confirm its superiority. We conducted this study to compare the efficiency of these two procedures.
The subjects of this retrospective analysis were 103 patients with left-sided PDAC who underwent either RAMPS (n = 46) or CDPS (n = 57). We assessed perioperative data and surgical information and used univariate and multivariate analyses to identify prognostic factors for survival.
There were no significant differences in baseline data between the groups. RAMPS was associated with a significantly shorter hospital stay (12.11 days vs. 22.98 days; P < 0.001), and significantly less blood loss (451.09 ml vs. 764.04 ml, P = 0.002), as well as a significantly lower rate of blood transfusion (15.22% vs. 33.33%, P = 0.035). RAMPS and CDPS had comparable perioperative complication rates. Moreover, RAMPS achieved more effective lymph-node retrieval (17.87 vs. 10.23; P < 0.001). The RAMPS group had a higher overall survival (OS) rate (28.73 months vs. 18.30 months; P = 0.003) and a higher disease-free survival (DFS) rate (21.97 months vs. 9.40 months; P < 0.001).
RAMPS achieved better survival and surgical outcomes than CDPS for patients with left-sided PDAC.
由于区域淋巴结清扫不充分和无法达到 RO 切除率,传统的胰体尾切除术(CDPS)后左侧胰腺导管腺癌(PDAC)可能发生转移。根治性顺行模块胰体尾切除术(RAMPS)旨在通过更好的淋巴结清扫来更成功地实现 RO 切除,但仍缺乏其短期和长期结果的充分证据来证实其优势。我们进行这项研究是为了比较这两种手术的效果。
本回顾性分析的对象是 103 例接受 RAMPS(n=46)或 CDPS(n=57)治疗的左侧 PDAC 患者。我们评估了围手术期数据和手术信息,并使用单因素和多因素分析来确定生存的预后因素。
两组患者的基线数据无显著差异。RAMPS 组的住院时间(12.11 天 vs. 22.98 天;P<0.001)、出血量(451.09ml vs. 764.04ml,P=0.002)和输血率(15.22% vs. 33.33%,P=0.035)均显著较低。RAMPS 和 CDPS 的围手术期并发症发生率相当。此外,RAMPS 获得了更有效的淋巴结清除效果(17.87 个 vs. 10.23 个;P<0.001)。RAMPS 组的总生存率(OS)更高(28.73 个月 vs. 18.30 个月;P=0.003),无病生存率(DFS)更高(21.97 个月 vs. 9.40 个月;P<0.001)。
对于左侧 PDAC 患者,RAMPS 比 CDPS 获得了更好的生存和手术结果。